Promis Neurosciences Stock Price History
| PMN Stock | USD 0.94 0.02 2.17% |
Below is the normalized historical share price chart for ProMIS Neurosciences extending back to January 10, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ProMIS Neurosciences stands at 0.94, as last reported on the 1st of December, with the highest price reaching 1.00 and the lowest price hitting 0.94 during the day.
If you're considering investing in ProMIS Stock, it is important to understand the factors that can impact its price. ProMIS Neurosciences maintains Sharpe Ratio (i.e., Efficiency) of -0.0891, which implies the firm had a -0.0891% return per unit of risk over the last 3 months. ProMIS Neurosciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ProMIS Neurosciences' Risk Adjusted Performance of (0.06), variance of 21.66, and Coefficient Of Variation of (1,081) to confirm the risk estimate we provide.
At this time, ProMIS Neurosciences' Total Stockholder Equity is very stable compared to the past year. As of the 1st of December 2024, Common Stock Shares Outstanding is likely to grow to about 12.9 M, while Common Stock is likely to drop about 38.3 M. . As of the 1st of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.05, while Price To Sales Ratio is likely to drop 5,071. ProMIS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of July 2007 | 200 Day MA 1.5904 | 50 Day MA 1.0632 | Beta 0.614 |
ProMIS |
Sharpe Ratio = -0.0891
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PMN |
Estimated Market Risk
| 4.63 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.41 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ProMIS Neurosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ProMIS Neurosciences by adding ProMIS Neurosciences to a well-diversified portfolio.
Price Book 4.2248 | Enterprise Value Ebitda (1.74) | Price Sales 5.2 K | Shares Float 9.2 M | Wall Street Target Price 12.2165 |
ProMIS Neurosciences Stock Price History Chart
There are several ways to analyze ProMIS Stock price data. The simplest method is using a basic ProMIS candlestick price chart, which shows ProMIS Neurosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 16, 2024 | 1.38 |
| Lowest Price | November 25, 2024 | 0.92 |
ProMIS Neurosciences December 1, 2024 Stock Price Synopsis
Various analyses of ProMIS Neurosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ProMIS Stock. It can be used to describe the percentage change in the price of ProMIS Neurosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ProMIS Stock.| ProMIS Neurosciences Price Daily Balance Of Power | 0.33 | |
| ProMIS Neurosciences Price Rate Of Daily Change | 1.02 | |
| ProMIS Neurosciences Price Action Indicator | (0.02) |
ProMIS Neurosciences December 1, 2024 Stock Price Analysis
ProMIS Stock Price History Data
The price series of ProMIS Neurosciences for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 0.46 with a coefficient of variation of 12.59. The price distribution for the period has arithmetic mean of 1.12. The median price for the last 90 days is 1.07. The company completed stock split (1:60) on 28th of June 2022.| Open | High | Low | Close | Volume | ||
12/01/2024 | 0.94 | 1.00 | 0.94 | 0.94 | ||
| 11/29/2024 | 0.94 | 1.00 | 0.94 | 0.94 | 20,494 | |
| 11/27/2024 | 0.92 | 1.00 | 0.92 | 0.94 | 73,010 | |
| 11/26/2024 | 0.97 | 0.97 | 0.92 | 0.92 | 63,141 | |
| 11/25/2024 | 1.02 | 1.02 | 0.88 | 0.92 | 31,889 | |
| 11/22/2024 | 0.95 | 1.03 | 0.95 | 1.03 | 52,444 | |
| 11/21/2024 | 0.99 | 0.99 | 0.95 | 0.96 | 12,049 | |
| 11/20/2024 | 0.97 | 1.01 | 0.91 | 1.00 | 41,054 | |
| 11/19/2024 | 1.02 | 1.02 | 0.98 | 0.99 | 48,773 | |
| 11/18/2024 | 1.00 | 1.04 | 0.95 | 1.02 | 51,047 | |
| 11/15/2024 | 0.98 | 1.04 | 0.97 | 0.98 | 30,706 | |
| 11/14/2024 | 0.99 | 1.04 | 0.99 | 0.99 | 16,275 | |
| 11/13/2024 | 0.98 | 1.05 | 0.98 | 0.98 | 26,675 | |
| 11/12/2024 | 0.97 | 1.08 | 0.97 | 0.98 | 13,308 | |
| 11/11/2024 | 1.04 | 1.05 | 0.98 | 0.99 | 39,636 | |
| 11/08/2024 | 1.07 | 1.10 | 1.03 | 1.07 | 18,466 | |
| 11/07/2024 | 1.01 | 1.10 | 1.01 | 1.02 | 23,102 | |
| 11/06/2024 | 1.02 | 1.06 | 1.01 | 1.03 | 28,448 | |
| 11/05/2024 | 1.07 | 1.08 | 1.01 | 1.02 | 48,874 | |
| 11/04/2024 | 1.15 | 1.17 | 1.08 | 1.08 | 32,462 | |
| 11/01/2024 | 1.26 | 1.34 | 1.12 | 1.15 | 107,697 | |
| 10/31/2024 | 1.07 | 1.57 | 1.00 | 1.27 | 850,647 | |
| 10/30/2024 | 1.06 | 1.24 | 1.00 | 1.09 | 299,570 | |
| 10/29/2024 | 1.08 | 1.08 | 1.00 | 1.03 | 12,309 | |
| 10/28/2024 | 1.01 | 1.07 | 0.97 | 1.06 | 19,282 | |
| 10/25/2024 | 0.98 | 1.06 | 0.96 | 1.02 | 25,439 | |
| 10/24/2024 | 0.95 | 1.00 | 0.93 | 0.96 | 51,949 | |
| 10/23/2024 | 0.98 | 1.00 | 0.94 | 0.95 | 29,062 | |
| 10/22/2024 | 0.99 | 1.00 | 0.94 | 0.98 | 40,657 | |
| 10/21/2024 | 0.95 | 1.02 | 0.92 | 0.95 | 80,257 | |
| 10/18/2024 | 1.02 | 1.04 | 0.99 | 0.99 | 27,769 | |
| 10/17/2024 | 1.04 | 1.07 | 1.00 | 1.05 | 9,169 | |
| 10/16/2024 | 1.00 | 1.06 | 1.00 | 1.04 | 13,161 | |
| 10/15/2024 | 1.03 | 1.06 | 0.98 | 1.02 | 39,950 | |
| 10/14/2024 | 1.02 | 1.06 | 0.96 | 1.00 | 24,101 | |
| 10/11/2024 | 0.96 | 1.07 | 0.96 | 1.02 | 63,886 | |
| 10/10/2024 | 1.04 | 1.05 | 1.00 | 1.01 | 36,148 | |
| 10/09/2024 | 1.10 | 1.10 | 1.00 | 1.03 | 41,695 | |
| 10/08/2024 | 1.10 | 1.11 | 1.02 | 1.03 | 31,307 | |
| 10/07/2024 | 1.11 | 1.14 | 1.03 | 1.10 | 35,714 | |
| 10/04/2024 | 1.09 | 1.17 | 1.09 | 1.09 | 51,510 | |
| 10/03/2024 | 1.20 | 1.22 | 1.11 | 1.11 | 31,395 | |
| 10/02/2024 | 1.21 | 1.34 | 1.15 | 1.23 | 130,301 | |
| 10/01/2024 | 1.25 | 1.30 | 1.22 | 1.23 | 194,736 | |
| 09/30/2024 | 1.36 | 1.36 | 1.23 | 1.25 | 37,770 | |
| 09/27/2024 | 1.38 | 1.43 | 1.28 | 1.28 | 50,193 | |
| 09/26/2024 | 1.44 | 1.44 | 1.29 | 1.29 | 43,105 | |
| 09/25/2024 | 1.43 | 1.45 | 1.30 | 1.31 | 166,380 | |
| 09/24/2024 | 1.29 | 1.32 | 1.22 | 1.30 | 115,038 | |
| 09/23/2024 | 1.23 | 1.35 | 1.23 | 1.23 | 150,293 | |
| 09/20/2024 | 1.26 | 1.32 | 1.21 | 1.23 | 104,642 | |
| 09/19/2024 | 1.33 | 1.38 | 1.22 | 1.23 | 53,421 | |
| 09/18/2024 | 1.41 | 1.41 | 1.23 | 1.24 | 31,415 | |
| 09/17/2024 | 1.40 | 1.42 | 1.26 | 1.31 | 49,366 | |
| 09/16/2024 | 1.15 | 1.42 | 1.09 | 1.38 | 131,479 | |
| 09/13/2024 | 1.19 | 1.30 | 1.19 | 1.23 | 38,175 | |
| 09/12/2024 | 1.22 | 1.30 | 1.21 | 1.25 | 25,772 | |
| 09/11/2024 | 1.19 | 1.25 | 1.14 | 1.23 | 88,321 | |
| 09/10/2024 | 1.25 | 1.29 | 1.12 | 1.23 | 91,394 | |
| 09/09/2024 | 1.30 | 1.39 | 1.19 | 1.25 | 106,997 | |
| 09/06/2024 | 1.39 | 1.40 | 1.30 | 1.30 | 16,788 |
About ProMIS Neurosciences Stock history
ProMIS Neurosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ProMIS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ProMIS Neurosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ProMIS Neurosciences stock prices may prove useful in developing a viable investing in ProMIS Neurosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.3 M | 12.9 M | |
| Net Loss | -16.3 M | -17.1 M |
ProMIS Neurosciences Stock Technical Analysis
ProMIS Neurosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
ProMIS Neurosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ProMIS Neurosciences' price direction in advance. Along with the technical and fundamental analysis of ProMIS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ProMIS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (1.22) | |||
| Treynor Ratio | 2.49 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.04 | Revenue Per Share 0.001 | Return On Assets (4.81) | Return On Equity (10.99) |
The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.